A drug that lowers IGF-1 sharpened thinking in older dogs
☕ Includes a question for the family ↓
What long-lived animals teach usPart of a story we are following · 1 article · See every update
Here is some encouraging news for anyone who hopes to stay sharp with age. Scientists lowered a growth signal called IGF-1 in older dogs, and the dogs thought more quickly and stayed more engaged. This was done in dogs, not people, and it has not been tested in people yet.
In a randomized trial of 28 beagles aged 7 to 15 years, dogs given the drug octreotide did better than dogs given a placebo on tests of attention, focus and memory. Dogs are a useful stand-in for us because they develop age-related brain changes that resemble those in older people.
How the study worked
Researchers enrolled 28 older beagles who were already used to brain-skill testing. After 28 days of baseline testing, the dogs received either long-acting octreotide (10 mg, injected into a muscle) or a placebo, and then all were tested again for 28 days. The results were published on November 4, 2026 in Front Vet Sci. It was a small study in one breed, so it is a first step rather than the last word.
What is IGF-1, and why lower it?
IGF-1 is a messenger in the body that is tied to growth hormone. Think of it as a volume knob for growth. In earlier research across many species, lower growth hormone and IGF-1 signaling has been linked to longer life and better thinking late in life. Chronically high levels have been linked to trouble with memory, attention and planning.
Octreotide is a long-acting drug that turns that knob down. What nobody had clearly shown until now was whether doing so with a drug would help the thinking of animals that are simply growing old naturally.
What they found
The treated dogs did significantly better than the placebo dogs on all three kinds of brain tests.
| Skill tested | What the test looks at |
|---|---|
| Planning and flexibility | Can the dog switch to a new rule when the old one stops working? |
| Attention | Can the dog pick out the one thing that is different? |
| Spatial memory | Can the dog remember where something was a moment ago? |
The biggest change was in speed and engagement. Treated dogs answered faster and stayed more involved in the tasks. The authors say the drug improved how efficiently the dogs responded, especially on the planning and attention tests.
That matters because those skills, planning, switching gears and paying attention, are the ones that tend to slip as brains age. The results support the idea that IGF-1 signaling plays a real part in how well the brain works late in life.
What does this mean for people?
The researchers describe the older dog as a valuable testing ground for ideas about slowing age-related decline in thinking. Dogs live with us, share our homes and age on a human-like timeline, so what works in them can point scientists toward what to try next.
This study does not show that the drug works in people. For now, it is a promising clue that turning down IGF-1 signaling can help an aging brain work better.
What you can do today
Nothing about your daily routine needs to change because of this study, and there is nothing to ask a pharmacy for. The useful step is to read the journal’s summary at the link above and notice the three kinds of thinking the dogs were tested on: flexibility, attention and short-term memory. Those are good skills to keep in mind as you follow future news on brain aging.
For clinicians and researchers
Design: Randomized, placebo-controlled study in 28 aged beagle dogs (7-15 years) experienced in neuropsychological testing. After a 28-day baseline, dogs received long-acting octreotide (Sandostatin LAR, 10 mg, i.m.) or placebo, then 28 days of post-treatment testing.
Main result: Treated dogs performed significantly better than placebo across discrimination reversal, variable oddity and variable delayed non-matching to position, mainly through reduced response latency and task engagement. No effect sizes or confidence intervals are given in the abstract.
Main limitation: Small sample (n=28) in a single species with short testing (28 days post-treatment). Gains were mainly in response latency and engagement, and IGF-1 suppression is inferred rather than shown in the abstract.
Open question: Whether the benefit persists with longer treatment, reflects true cognitive gains rather than response efficiency, and translates to humans remains to be tested.
Talk about it at home
Scientists gave older beagles puzzle games, like spotting the odd item out, switching to a new rule, and remembering where something was a moment ago. They worked with a body messenger that acts like the volume knob on a radio, turning growth signals up or down, and they turned that knob down a little. The dogs answered faster and paid closer attention than the dogs in the comparison group, though this was only tested in dogs so far.
Try it at home
Ask a grandparent or an older neighbor which pets they had when they were young, what clever things those pets knew how to do, and how they noticed their pets learning new things.
Keep exploring
Copies this article and its questions so you can paste them into ChatGPT, Claude, Gemini or the AI you use, and keep the conversation going.
Cite this article
Mongevity Desk. A drug that lowers IGF-1 sharpened thinking in older dogs. Mongevity. Published November 22, 2026. Accessed November 22, 2026. https://mongevity.science/aging/2026/11/igf-1-drug-sharpened-thinking-older-dogs/Mongevity Desk. A drug that lowers IGF-1 sharpened thinking in older dogs [Internet]. Mongevity; 2026 Nov 22 cited 2026 Nov 22]. Available from: https://mongevity.science/aging/2026/11/igf-1-drug-sharpened-thinking-older-dogs/Mongevity Desk. (2026, November 22). A drug that lowers IGF-1 sharpened thinking in older dogs. Mongevity. https://mongevity.science/aging/2026/11/igf-1-drug-sharpened-thinking-older-dogs/
<a href="https://mongevity.science/aging/2026/11/igf-1-drug-sharpened-thinking-older-dogs/">A drug that lowers IGF-1 sharpened thinking in older dogs</a>
Free to share or quote with credit and a link.
Questions and answers
- What is IGF-1?
- IGF-1 is a messenger in the body linked to growth hormone. Lower levels have been tied to longer life and better thinking in later years across many species.
- What did the older dogs get?
- The 28 beagles received either long-acting octreotide, a drug that lowers IGF-1 signaling, or a placebo.
- What improved in the treated dogs?
- They did better than the placebo dogs on tests of planning and flexibility, attention and spatial memory. The biggest change was faster answers and more engagement.
- Does this work in people?
- That is not known. The study was done in dogs only, and nothing about it changes advice for people today.